Toll Free: 1-888-928-9744

Global RNAi for Therapeutic Detailed Analysis Report 2017-2022

Published: Aug 9, 2017 | Pages: 128 | Publisher: Detailed-Analysis Research (DAR) | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in RNAi for Therapeutic industry.

This report splits RNAi for Therapeutic market By Technology, By Molecular Form, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies
    Alnylam Pharmaceuticals (USA)
    Arbutus Biopharma (Tekmira) (Canada)
    Arrowhead Research (USA)
    Dicerna Pharmaceuticals (USA)
    Mirna Therapeutics (USA)
    Quark Pharmaceuticals (Israel)
    RXi Pharmaceuticals (USA)
    Silence Therapeutics (Germany)
    Benitec Biopharma (Australia)
    miRagen Therapeutics (USA)
    Sylentis (Spain)
    Gradalis (USA)
    Sirnaomics (USA)
    Silenseed (Israel)
    Arcturus Therapeutics (USA)
    Arcturus Therapeutics (USA)
    Ariz Biopharma (USA)
    GeneCopoeia (USA)
    Ascletis Pharmaceuticals (USA)
    Celsion Corporation (USA)
    Astellas Pharma (USA)
    AstraZeneca (UK)
    BioSpring (Vietnam)
    Calando Pharmaceuticals (USA)
    Celgene (USA)
    Bayer Heathcare (USA)
    Biogazelle (Belgium)
    CombiMatrix (USA)
    Creative Animodel (USA)
    Ensysce Biosciences (USA)

Main Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main Product Type
RNAi for Therapeutic Market, by Technology
    siRNA
    miRNA
    shRNA
RNAi for Therapeutic Market, by Molecular Form
    Single Chain
    Double Chain

Main Applications
    Cancer
    Cardiovascular
    HBV
    Other

 Table of Contents

Global RNAi for Therapeutic Detailed Analysis Report 2017-2022
Chapter One RNAi for Therapeutic Market Overview
    1.1 Global RNAi for Therapeutic Market Sales Volume Revenue and Price 2012-2022
    1.2 RNAi for Therapeutic, By Technology 2012-2022
        1.2.1 Global RNAi for Therapeutic Sales Market Share by Technology 2012-2022
        1.2.2 Global RNAi for Therapeutic Revenue Market Share by Technology 2012-2022
        1.2.3 Global RNAi for Therapeutic Price by Technology 2012-2022
        1.2.4 siRNA
        1.2.5 miRNA
        1.2.6 shRNA
    1.3 RNAi for Therapeutic, by Molecular Form 2012-2022
        1.3.1 Global RNAi for Therapeutic Sales Market Share by Molecular Form 2012-2022
        1.3.2 Global RNAi for Therapeutic Revenue Market Share by Molecular Form 2012-2022
        1.3.3 Global RNAi for Therapeutic Price by Molecular Form 2012-2022
        1.3.4 Single Chain
        1.3.5 Double Chain

Chapter Two RNAi for Therapeutic by Regions 2012-2017
    2.1 Global RNAi for Therapeutic Sales Market Share by Regions 2012-2017
    2.2 Global RNAi for Therapeutic Revenue Market Share by Regions 2012-2017
    2.3 Global RNAi for Therapeutic Price by Regions 2012-2017
    2.4 North America
        2.4.1 United States
        2.4.2 Canada
    2.5 Latin America
        2.5.1 Mexico
        2.5.2 Brazil
        2.5.3 Argentina
        2.5.4 Others in Latin America
    2.6 Europe
        2.6.1 Germany
        2.6.2 United Kingdom
        2.6.3 France
        2.6.4 Italy
        2.6.5 Spain
        2.6.6 Russia
        2.6.7 Netherland
        2.6.8 Others in Europe
    2.7 Asia & Pacific
        2.7.1 China
        2.7.2 Japan
        2.7.3 India
        2.7.4 Korea
        2.7.5 Australia
        2.7.6 Southeast Asia
            2.7.6.1 Indonesia
            2.7.6.2 Thailand
            2.7.6.3 Philippines
            2.7.6.4 Vietnam
            2.7.6.5 Singapore
            2.7.6.6 Malaysia
            2.7.6.7 Others in Southeast Asia
    2.8 Africa & Middle East
        2.8.1 South Africa
        2.8.2 Egypt
        2.8.3 Turkey
        2.8.4 Saudi Arabia
        2.8.5 Iran
        2.8.6 Others in Africa & Middle East

Chapter Three RNAi for Therapeutic by Players 2012-2017
    3.1 Global RNAi for Therapeutic Sales Volume Market Share by Players 2012-2017
    3.2 Global RNAi for Therapeutic Revenue Share by Players 2012-2017
    3.3 Global Top Players RNAi for Therapeutic Key Product Model and Market Performance
    3.4 Global Top Players RNAi for Therapeutic Key Target Consumers and Market Performance

Chapter Four RNAi for Therapeutic by Consumer 2012-2017
    4.1 Global RNAi for Therapeutic Sales Market Share by Consumer 2012-2017
    4.2 Cancer
    4.3 Cardiovascular
    4.4 HBV
    4.5 Other
    4.6 Consuming Habit and Preference

Chapter Five Global Top Players Profile
    5.1 Alnylam Pharmaceuticals (USA)
        5.1.1 Alnylam Pharmaceuticals (USA) Company Details and Competitors
        5.1.2 Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        5.1.3 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.1.4 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.2 Arbutus Biopharma (Tekmira) (Canada)
        5.2.1 Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
        5.2.2 Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
        5.2.3 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.2.4 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.3 Arrowhead Research (USA)
        5.3.1 Arrowhead Research (USA) Company Details and Competitors
        5.3.2 Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
        5.3.3 Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.3.4 Arrowhead Research (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.4 Dicerna Pharmaceuticals (USA)
        5.4.1 Dicerna Pharmaceuticals (USA) Company Details and Competitors
        5.4.2 Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        5.4.3 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.4.4 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.5 Mirna Therapeutics (USA)
        5.5.1 Mirna Therapeutics (USA) Company Details and Competitors
        5.5.2 Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
        5.5.3 Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.5.4 Mirna Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.6 Quark Pharmaceuticals (Israel)
        5.6.1 Quark Pharmaceuticals (Israel) Company Details and Competitors
        5.6.2 Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
        5.6.3 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.6.4 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.7 RXi Pharmaceuticals (USA)
        5.7.1 RXi Pharmaceuticals (USA) Company Details and Competitors
        5.7.2 RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        5.7.3 RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.7.4 RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.8 Silence Therapeutics (Germany)
        5.8.1 Silence Therapeutics (Germany) Company Details and Competitors
        5.8.2 Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
        5.8.3 Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.8.4 Silence Therapeutics (Germany) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.9 Benitec Biopharma (Australia)
        5.9.1 Benitec Biopharma (Australia) Company Details and Competitors
        5.9.2 Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
        5.9.3 Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.9.4 Benitec Biopharma (Australia) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.10 miRagen Therapeutics (USA)
        5.10.1 miRagen Therapeutics (USA) Company Details and Competitors
        5.10.2 miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
        5.10.3 miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        5.10.4 miRagen Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    5.11 Sylentis (Spain)
    5.12 Gradalis (USA)
    5.13 Sirnaomics (USA)
    5.14 Silenseed (Israel)
    5.15 Arcturus Therapeutics (USA)
    5.16 Arcturus Therapeutics (USA)
    5.17 Ariz Biopharma (USA)
    5.18 GeneCopoeia (USA)
    5.19 Ascletis Pharmaceuticals (USA)
    5.20 Celsion Corporation (USA)
    5.21 Astellas Pharma (USA)
    5.22 AstraZeneca (UK)
    5.23 BioSpring (Vietnam)
    5.24 Calando Pharmaceuticals (USA)
    5.25 Celgene (USA)
    5.26 Bayer Heathcare (USA)
    5.27 Biogazelle (Belgium)
    5.28 CombiMatrix (USA)
    5.29 Creative Animodel (USA)
    5.30 Ensysce Biosciences (USA)

Chapter Six Industry Chain and Supply Chain
    6.1 RNAi for Therapeutic Industry Chain Structure
        6.1.1 R&D
        6.1.2 Raw Materials (Components)
        6.1.3 Manufacturing Plants
        6.1.4 Regional Trading (Import Export and Local Sales)
        6.1.5 Online Sales Channel
        6.1.6 Offline Channel
        6.1.7 End Users
    6.2 RNAi for Therapeutic Manufacturing
        6.2.1 Key Components
        6.2.2 Assembly Manufacturing
    6.3 Consumer Preference
    6.4 Behavioral Habits
    6.5 Marketing Environment

Chapter Seven Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2017-2022)
    7.1 Global RNAi for Therapeutic Sales (Million Units), Revenue (Million USD) Forecast (2017-2022)
    7.2 Global RNAi for Therapeutic Sales (Million Units) Forecast by Regions (2017-2022)
    7.3 Global RNAi for Therapeutic Sales (Million Units) Forecast by Application (2017-2022)
    7.4 Global RNAi for Therapeutic Sales (Million Units) Forecast by Technology (2017-2022)
    7.5 Global RNAi for Therapeutic Sales (Million Units) Forecast by Molecular Form (2017-2022)

Chapter Eight Development Trend and Research Conclusion
    8.1 Development Trend
    8.2 Research Conclusion

Chapter Nine Methodology and Data Source
    9.1 Methodology/Research Approach
        9.1.1 Research Programs/Design
        9.1.2 Market Size Estimation
        9.1.3 Market Breakdown and Data Triangulation
    9.2 Data Source
        9.2.1 Secondary Sources
        9.2.2 Primary Sources
    9.3 Disclaimer


List of Tables and Figures

    Table Global RNAi for Therapeutic Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global RNAi for Therapeutic Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by Technology (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by Technology (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Technology in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by Technology (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Technology (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Technology in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Technology (2012-2017)
    Table Top Players of siRNA RNAi for Therapeutic Products List
    Figure Global siRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of miRNA RNAi for Therapeutic Products List
    Figure Global miRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of shRNA RNAi for Therapeutic Products List
    Figure Global shRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by Molecular Form (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by Molecular Form (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Molecular Form in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by Molecular Form (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Molecular Form (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Molecular Form in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Molecular Form (2012-2017)
    Table Top Players of Single Chain RNAi for Therapeutic Products List
    Figure Global Single Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Double Chain RNAi for Therapeutic Products List
    Figure Global Double Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Global RNAi for Therapeutic Sales Share by Regions (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2016
    Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2017
    Table Global RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Regions (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2016
    Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2017
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure North America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Latin America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Latin America RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Latin America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Europe RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Europe RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Europe RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Asia & Pacific RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Southeast Asia RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Southeast Asia RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Southeast Asia RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Southeast Asia RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Africa & Middle East RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Table Global RNAi for Therapeutic Sales Volume Market Share by Key Players (2012-2017)
    Figure Global RNAi for Therapeutic Sales Volume Market Share by Key Players 2016
    Figure Global RNAi for Therapeutic Sales Volume Market Share by Key Players 2017
    Table Global RNAi for Therapeutic Revenue (Million USD) by Key Players (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Key Players (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Key Players 2016
    Figure Global RNAi for Therapeutic Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Global RNAi for Therapeutic Sales (K Pcs) by Consumer (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Consumer (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Consumer in 2016
    Figure Global Cancer RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Cardiovascular RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global HBV RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Other RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Alnylam Pharmaceuticals (USA) Company Details and Competitors
    Table Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
    Table Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
    Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Arrowhead Research (USA) Company Details and Competitors
    Table Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
    Table Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Arrowhead Research (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Dicerna Pharmaceuticals (USA) Company Details and Competitors
    Table Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Mirna Therapeutics (USA) Company Details and Competitors
    Table Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
    Table Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Mirna Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Quark Pharmaceuticals (Israel) Company Details and Competitors
    Table Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
    Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table RXi Pharmaceuticals (USA) Company Details and Competitors
    Table RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Silence Therapeutics (Germany) Company Details and Competitors
    Table Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
    Table Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Silence Therapeutics (Germany) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Benitec Biopharma (Australia) Company Details and Competitors
    Table Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
    Table Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Benitec Biopharma (Australia) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table miRagen Therapeutics (USA) Company Details and Competitors
    Table miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
    Table miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table miRagen Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2022)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2022)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2022)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2022)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2022)
    Table Sylentis (Spain) Company Details and Competitors
    Table Gradalis (USA) Company Details and Competitors
    Table Sirnaomics (USA) Company Details and Competitors
    Table Silenseed (Israel) Company Details and Competitors
    Table Arcturus Therapeutics (USA) Company Details and Competitors
    Table Arcturus Therapeutics (USA) Company Details and Competitors
    Table Ariz Biopharma (USA) Company Details and Competitors
    Table GeneCopoeia (USA) Company Details and Competitors
    Table Ascletis Pharmaceuticals (USA) Company Details and Competitors
    Table Celsion Corporation (USA) Company Details and Competitors
    Table Astellas Pharma (USA) Company Details and Competitors
    Table AstraZeneca (UK) Company Details and Competitors
    Table BioSpring (Vietnam) Company Details and Competitors
    Table Calando Pharmaceuticals (USA) Company Details and Competitors
    Table Celgene (USA) Company Details and Competitors
    Table Bayer Heathcare (USA) Company Details and Competitors
    Table Biogazelle (Belgium) Company Details and Competitors
    Table CombiMatrix (USA) Company Details and Competitors
    Table Creative Animodel (USA) Company Details and Competitors
    Table Ensysce Biosciences (USA) Company Details and Competitors
    Figure Global RNAi for Therapeutic Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global RNAi for Therapeutic Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
    Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Technology in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
    Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Molecular Form in 2022

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...
Choose License Type
Single User - US $3250
Multi User - US $6500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify